Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul A. Raju is active.

Publication


Featured researches published by Paul A. Raju.


Journal of Clinical Investigation | 1995

CD8 naive T cell counts decrease progressively in HIV-infected adults.

Mario Roederer; J.G. Dubs; Michael T. Anderson; Paul A. Raju; Leonore A. Herzenberg

We show here that CD8 naive T cells are depleted during the asymptomatic stage of HIV infection. Although overall CD8 T cell numbers are increased during this stage, the naive CD8 T cells are progressively lost and fall in parallel with overall CD4 T cell counts. In addition, we show that naive CD4 T cells are preferentially lost as total CD4 cell counts fall. These findings, presented here for adults, and in the accompanying study for children, represent the first demonstration that HIV disease involves the loss of both CD4 T cells and CD8 T cells. Furthermore, they provide a new insight into the mechanisms underlying the immunodeficiency of HIV-infected individuals, since naive T cells are required for all new T cell-mediated immune responses. Studies presented here also show that the well-known increase in total CD8 counts in most HIV-infected individuals is primarily due to an expansion of memory cells. Thus, memory CD8 T cells comprise over 80% of the T cells in PBMC from individuals with < 200 CD4/microliter, whereas they comprise roughly 15% in uninfected individuals. Since the naive and memory subsets have very different functional activities, this altered naive/memory T cell representation has significant consequences for the interpretation of data from in vitro functional studies.


Journal of Clinical Investigation | 1997

HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28.

Mario Roederer; Paul A. Raju; Dipendra K. Mitra; Leonard A. Herzenberg

In this report, we demonstrate that the T cell tropic strain of HIV, LAI, does not replicate in naive CD4 T cells stimulated by cross-linking CD3 and CD28. In contrast, LAI replicates well in memory CD4 T cells stimulated in the same way. Unlike this physiologically relevant stimulation, PHA stimulates productive LAI replication in both naive and memory T cells. These studies were conducted with highly purified (FACS-isolated) subsets of CD4 T cells identified by expression of both CD45RA and CD62L. Remixing of purified T cells showed that naive T cells do not suppress LAI replication in memory T cells and that memory T cells do not restore LAI expression in naive T cells. The suppression of productive LAI replication in naive T cells is not due to differential expression of viral coreceptors, nor is it due to inhibition of activation of the important HIV transcription factors, nuclear factor-kappaB and activator protein-1. The inherent resistance of naive T cells to productive HIV infection, coupled with their proliferative advantage as demonstrated here, provides a sound basis for proposed clinical therapies using ex vivo expansion and reinfusion of CD4 T cells from HIV-infected adults.


The Journal of Allergy and Clinical Immunology | 2017

Evidence for altered levels of IgD in the nasal airway mucosa of patients with chronic rhinosinusitis

Jin Young Min; Jayakar V. Nayak; Kathryn E. Hulse; Whitney W. Stevens; Paul A. Raju; Julia H. Huang; Lydia Suh; Griet A. Van Roey; James Norton; Roderick G. Carter; Caroline P.E. Price; Ava R. Weibman; Ali R. Rashan; Eliver Eid Bou Ghosn; Zara M. Patel; Tetsuya Homma; David B. Conley; Kevin C. Welch; Stephanie Shintani-Smith; Anju T. Peters; Leslie C. Grammer; Kathleen E. Harris; Atsushi Kato; Peter H. Hwang; Robert C. Kern; Leonore A. Herzenberg; Robert P. Schleimer; Bruce K. Tan

Background: IgD is an enigmatic antibody isotype best known when coexpressed with IgM on naive B cells. However, increased soluble IgD (sIgD) levels and increased IgD+IgM− B‐cell populations have been described in the human upper respiratory mucosa. Objective: We assessed whether levels of sIgD and IgD+ B cell counts are altered in nasal tissue from patients with chronic rhinosinusitis (CRS). We further characterized IgD+ B‐cell populations and explored clinical and local inflammatory factors associated with tissue sIgD levels. Methods: sIgD levels were measured by means of ELISA in nasal tissues, nasal lavage fluid, sera, and supernatants of dissociated nasal tissues. IgD+ cells were identified by using immunofluorescence and flow cytometry. Inflammatory mediator levels in tissues were assessed by using real‐time PCR and multiplex immunoassays. Bacterial cultures from the middle meatus were performed. Underlying medical history and medicine use were obtained from medical records. Results: sIgD levels and numbers of IgD+ cells were significantly increased in uncinate tissue (UT) of patients with chronic rhinosinusitis without nasal polyps (CRSsNP) compared with that of control subjects (4‐fold, P < .05). IgD+ cells were densely scattered in the periglandular regions of UT from patients with CRSsNP. We also found that IgD+CD19+CD38bright plasmablast numbers were significantly increased in tissues from patients with CRSsNP compared with control tissues (P < .05). Among numerous factors tested, IL‐2 levels were increased in UT from patients with CRSsNP and were positively correlated with tissue IgD levels. Additionally, supernatants of IL‐2–stimulated dissociated tissue from patients with CRSsNP had significantly increased sIgD levels compared with those in IL‐2–stimulated dissociated control tissue ex vivo (P < .05). Tissue from patients with CRS with preoperative antibiotic use or those with pathogenic bacteria showed higher IgD levels compared with tissue from patients without these variables (P < .05). Conclusion: sIgD levels and IgD+CD19+CD38bright plasmablast counts were increased in nasal tissue of patients with CRSsNP. IgD levels were associated with increased IL‐2 levels and the presence of pathogenic bacteria. These findings suggest that IgD might contribute to enhancement mucosal immunity or inflammation or respond to bacterial infections in patients with CRS, especially CRSsNP.


Proceedings of the National Academy of Sciences of the United States of America | 1990

Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine.

Mario Roederer; Frank J.T. Staal; Paul A. Raju; Stephen W. Ela; Leonore A. Herzenberg


AIDS Research and Human Retroviruses | 1992

Intracellular Glutathione Levels in T Cell Subsets Decrease in HIV-Infected Individuals

Frank J.T. Staal; Mario Roederer; Dennis M. Israelski; Jeff Bubp; Larry A. Mole; Dennis McShane; Stanley C. Deresinski; William Ross; Howard H. Sussman; Paul A. Raju; Michael T. Anderson; Wayne A. Moore; Stephen W. Ela; Leonore A. Herzenberg; Leonard A. Herzenberg


AIDS Research and Human Retroviruses | 1993

Antioxidants Inhibit Stimulation of HIV Transcription

Frank J.T. Staal; Mario Roederer; Paul A. Raju; Michael T. Anderson; Stephen W. Ela; Leonard A. Herzenberg; Leonore A. Herzenberg


AIDS Research and Human Retroviruses | 1991

N-ACETYLCYSTEINE INHIBITS LATENT HIV EXPRESSION IN CHRONICALLY INFECTED CELLS

Mario Roederer; Paul A. Raju; Frank J.T. Staal; Leonore A. Herzenberg; Leonard A. Herzenberg


AIDS Research and Human Retroviruses | 1994

Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication.

Paul A. Raju; Leonore A. Herzenberg; Leonard A. Herzenberg; Mario Roederer


Annals of the New York Academy of Sciences | 1993

Disregulation of Leukocyte Glutathione in AIDS

Mario Roederer; Frank J.T. Staal; Michael T. Anderson; Ron Rabin; Paul A. Raju; Leonore A. Herzenberg; Leonard A. Herzenberg


Cancer Research | 1995

ET-18-OCH3 Inhibits Nuclear Factor-κB Activation by 12-O-Tetradecanoylphorbol-13-acetate but not by Tumor Necrosis Factor-α or Interleukin 1α

Larry W. Daniel; Francesca Civoli; Michael A. Rogers; Pamela K. Smitherman; Paul A. Raju; Mario Roederer

Collaboration


Dive into the Paul A. Raju's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mario Roederer

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge